The MULTI-X platform simplifies the logistical challenges of deploying AI and ML solutions by providing pre-configured environments with ad-hoc scalable computing resources to quickly build, test, share and reproduce scientific applications. Its comprehensible modular framework accelerates the development and reduces the burden and cost of implementing AI solutions. The talk will include details of two exemplary deployments in the area of Cardiac Image Analysis, presented together with the outcome of the analysis of 5000 subjects of the UK-Biobank database. Developing and deploying AI solutions for clinical research use cases can be complex, resource intensive, and therefore expensive and challenging to implement for many researchers, groups and healthcare organisations. In the era of Big-Data and the IoT, the most critical problems are related to the secure access and management of large heterogeneous datasets, the deployment of GPU-accelerated massive parallel processing systems, and the setup of development environments encompassing complex ML tools and applications. Two exemplary use cases of the implementation of GPU-enabled AI solutions in the area of Cardiac Image Analysis, both developed and deployed in MULTI-X, will be presented together with the outcome of the analysis of 5000 Subjects of the UK-Biobank database.
The increasing availability of large medical imaging data resources with associated clinical data, combined with the advances in the field of machine learning, hold large promises for disease diagnosis, prognosis, therapy planning and therapy monitoring. As a result, the number of researchers and companies active in this field has grown exponentially, resulting in a similar increase in the number of papers and algorithms. A number of issues need to be addressed to increase the clinical impact of the machine learning revolution in radiology. First, it is essential that machine learning algorithms can be seamlessly integrated in the clinical workflow. Second, the algorithm should be sufficiently robust and accurate, especially in view of data heterogeneity in clinical practice. Third, the additional clinical value of the algorithm needs to be evaluated. Fourth, it requires considerable resources to obtain regulatory approval for machine learning based algorithms. In this workshop, the ACR and MICCAI Society will bring together expertise from radiology, medical image computing and machine learning, to start a joint effort to address the issues above.
This talk will overview the fields of Personalised Computational Medicine and In Silico Clinical Trials, which are revolutionizing Medicine and Medical Product Development. This talk will introduce these concepts, provide examples of how they can transform healthcare, and emphasize why artificial intelligence and machine learning are relevant to them. We will also explain the limitations of these approaches and why it is paramout to engage in both phenomenological (data-driven) and mechanistic (principle-driven) modelling. Both areas are in desperate need for better infrastructures -sofrware and hardaware- giving access to computational and storage resources. The talk will be thought-provoking and eye-opening as to opportunities in this space for researchers and industries alike.